OTCMKTS:GTHP

Guided Therapeutics (GTHP) Stock Price, News & Analysis

Guided Therapeutics logo
$0.11 -0.01 (-8.33%)
As of 10:15 AM Eastern

About Guided Therapeutics Stock (OTCMKTS:GTHP)

Advanced

Key Stats

Today's Range
$0.11
▼
$0.11
50-Day Range
$0.10
▼
$0.25
52-Week Range
$0.10
▼
$0.54
Volume
3,200 shs
Average Volume
27,274 shs
Market Capitalization
$10.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Guided Therapeutics is a medical technology company focused on developing tools for the detection of cervical disease. Its principal product is the LuViva Advanced Cervical Scan, a non-invasive device designed to assess cervical tissue for signs associated with precancerous changes and cancer.

LuViva uses optical technologies to examine tissue and provide information that can support cervical disease evaluation. The company’s work centers on offering an alternative to diagnostic approaches that rely on collecting and analyzing tissue samples.

AI Generated. May Contain Errors.

Guided Therapeutics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
3rd Percentile Overall Score

GTHP MarketRank™: 
0.14974821097 of 5 stars

Guided Therapeutics scored higher than 3% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Guided Therapeutics.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Guided Therapeutics is -2.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Guided Therapeutics is -2.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

    0.01% of the float of Guided Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Guided Therapeutics has a short interest ratio ("days to cover") of 0.03, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Guided Therapeutics has recently increased by 63.40%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Guided Therapeutics does not currently pay a dividend.

  • Dividend Growth

    Guided Therapeutics does not have a long track record of dividend growth.

  • News Sentiment

    Guided Therapeutics has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.59 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Guided Therapeutics this week, compared to 0 articles on an average week.
  • Search Interest

    Only 1 people have searched for GTHP on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Guided Therapeutics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    66.83% of the stock of Guided Therapeutics is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    9.69% of the stock of Guided Therapeutics is held by institutions.

  • Read more about Guided Therapeutics' insider trading history.
Receive GTHP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Guided Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GTHP Stock News Headlines

You missed yesterday's deadline…
In June 2025, a drilling crew near the Grand Canyon uncovered an energy source producing nearly eight times the output of Saudi Arabia's largest oil well, enough potential energy to power civilization for two million years. While the One Big Beautiful Bill Act stripped tax credits from solar, wind, and EVs on July 4th, this discovery was reclassified alongside oil and nuclear and secured eight years of credits. Google signed a 15-year contract, and Bill Gates committed 100 million dollars.tc pixel
See More Headlines

GTHP Stock Analysis - Frequently Asked Questions

Guided Therapeutics' stock was trading at $0.54 at the start of the year. Since then, GTHP stock has decreased by 79.6% and is now trading at $0.11.

Guided Therapeutics Inc. (OTCMKTS:GTHP) released its earnings results on Monday, November, 16th. The company reported ($0.01) EPS for the quarter.

Shares of GTHP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
11/16/2026
Last Earnings
11/16/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
OTCMKTS:GTHP
CIK
924515
Employees
3
Year Founded
1992

Profitability

EPS (Trailing Twelve Months)
($0.04)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$3.20 million
Net Margins
N/A
Pretax Margin
-471.23%
Return on Equity
N/A
Return on Assets
-243.93%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.09
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$770 thousand
Price / Sales
14.03
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.09) per share
Price / Book
-1.22

Miscellaneous

Outstanding Shares
98,188,000
Free Float
32,569,000
Market Cap
$10.80 million
Optionable
Not Optionable
Beta
0.78

Social Links

10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

This page (OTCMKTS:GTHP) was last updated on 11/16/2026 by MarketBeat.com Staff.
From Our Partners